Improving Outcome of Hodgkins Disease with Autologous Hematopoietic Stem Cell Transplantation.

about

Improving Outcome of Hodgkins Disease with Autologous Hematopoietic Stem Cell Transplantation.

Item

http://www.wikidata.org/entity/Q38955399

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Improving Outcome of Hodgkins ...... tic Stem Cell Transplantation.

@en

type

Item

label

Improving Outcome of Hodgkins ...... tic Stem Cell Transplantation.

@en

prefLabel

Improving Outcome of Hodgkins ...... tic Stem Cell Transplantation.

@en

P1476

Improving Outcome of Hodgkins ...... tic Stem Cell Transplantation.

@en

P2093

Akhil Jain

http://www.w3.org/2001/XMLSchema#string

Apurva Patel

http://www.w3.org/2001/XMLSchema#string

Asha Anand

http://www.w3.org/2001/XMLSchema#string

Harsha Panchal

http://www.w3.org/2001/XMLSchema#string

Kamalesh Shah

http://www.w3.org/2001/XMLSchema#string

Kinnari Patel

http://www.w3.org/2001/XMLSchema#string

Sandip Shah

http://www.w3.org/2001/XMLSchema#string

Shailesh Talati

http://www.w3.org/2001/XMLSchema#string

Shreeniwas Raut

http://www.w3.org/2001/XMLSchema#string

Sonia Parikh

http://www.w3.org/2001/XMLSchema#string

P2860

Standard therapy of advanced Hodgkin lymphoma

Early-stage Hodgkin's lymphoma.

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.

Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

P2888

s12288-015-0559-5

P304

176-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12288-015-0559-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27065579

http://www.w3.org/2001/XMLSchema#string

P932

4789010

http://www.w3.org/2001/XMLSchema#string